Management of Neurologic Diseases

  • Authors: David M. Simpson, MD; Jessica Robinson-Papp, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/1/16 (What's New)

Summary

  • HIV-associated CNS infections and malignancies include parenchymal lesions and meningoencephalitis
  • Incidence has declined with availability of effective ART
    • Risk is increased in persons with CD4+ cell count < 200 cells/mm3 or HIV-1 RNA > 100,000 copies/mL
    • Parenchymal Mass Lesions
      Treatment
        Impact of CD4+ Cell Count
          Use of Corticosteroids
          Infiltrative Parenchymal Lesions

          Action required

          Keywords: Cancer, IRIS, Neurologic Complications

          ©2018 Clinical Care Options, LLC. All Rights Reserved.

          The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.